Shares of Amkor Technology rocketed 20.8% to $78.89 in after-hours trading on July 23, blowing past a consensus analyst target of $78, after Fitch Ratings affirmed the chipmaker's credit rating at 'BB+' — one notch below investment grade — and upgraded its outlook to Stable. The catalyst: Fitch's endorsement of Amkor's massive Arizona expansion as a credible growth driver. With Q2 earnings due July 27, the timing supercharges the move — but raises a hard question about whether a credit-rating action justifies this kind of price spike.
A $7 Billion Factory Bet Gets a Credibility Boost
Amkor has expanded its total Arizona investment to $7 billion across two phases, building packaging and testing facilities with 750,000 square feet of cleanroom space.
The campus will complement TSMC's nearby wafer fabs, serving customers like Apple and Nvidia. Fitch's stable outlook signals that the agency believes Amkor can digest this spending without destabilizing its balance sheet — a meaningful vote of confidence for a company rated just below investment grade.
The Cash Flow Math Is Uncomfortable That confidence comes with a caveat. Amkor's trailing levered free cash flow — the cash left after all operating costs, interest, and capital spending — stood at negative $47 million , and 2026 capital expenditures are guided at $2.5 billion to $3.0 billion, primarily for Arizona construction.
The company ended 2025 with $1.99 billion in cash against $1.45 billion in debt , but that cushion will shrink fast. Amkor is eligible for a 35% investment tax credit on qualified U.S. semiconductor investments under the CHIPS Act , a crucial subsidy to soften the blow.
The Stock Has Already Priced In a Lot of Good News Before today's spike, AMKR traded at a trailing P/E of 38.4x on diluted EPS of $1.75. At $78.89, the P/E stretches above 45x — rich for a packaging company with sub-7% profit margins. Q1 2026 revenue hit $1.68 billion, up 27% year-over-year , and Q2 guidance calls for $1.75–$1.85 billion in sales. Growth is real, but a Fitch affirmation is not an earnings beat.
Timing Raises the Stakes
Amkor reports Q2 results on July 27 — three days away. If results disappoint, today's gap-up could reverse sharply. Investors buying here are essentially betting the earnings will ratify the credit agency's optimism. The Arizona story is compelling, but at 45x earnings with negative free cash flow, the margin for error just vanished.